Lithium Argentina (LAR) Q1 2026 Transcript

Lithium Argentina reported adjusted EBITDA of $106 million in Q1, more than 3x the prior quarter’s $30 million, as Cauchari-Olaroz produced 9,700 tons at under $5,400/ton cash cost and nearly 97% of nameplate capacity. Management kept 2026 production guidance at 35,000-40,000 tons and reiterated EBITDA potential of $460 million-$630 million at $20,000-$30,000/ton lithium prices, while highlighting $100 million in JV distributions year-to-date and a net debt ratio below 0.5x annualized Q1 EBITDA. The company also said Stage 2 permitting is progressing, with a possible RIGI approval this quarter and immaterial capex in 2026, plus plans for a secondary ASX listing without financing.

Analysis

LAR is transitioning from a story stock to a cash-yielding brine platform, and that matters because the market typically re-rates lithium names only when investors believe cash flow is durable through a cycle, not just from spot-price beta. The key second-order effect is that Stage 1 is now effectively funding Stage 2 optionality without forcing dilution, which should compress the company’s cost of capital versus peers that still need equity to grow. If management keeps converting EBITDA to cash at this pace, the balance sheet ceases to be a constraint and becomes a strategic asset in a sector where most competitors are still fighting for survival.

The biggest near-term catalyst is not volume growth; it is the narrowing of the realized-price discount. Every percentage point of discount compression has an outsized impact because the cost base is already near the floor, so incremental price capture flows disproportionately to EBITDA and distributable cash. That creates a setup where the stock can rerate faster than the underlying production ramp if the market begins to price in a higher-quality of earnings rather than just higher lithium prices.

The contrarian risk is that the market may be extrapolating too much too soon from a favorable quarter into a multi-year earnings stream. Stage 2 and PPG are still heavily permitting-dependent, and the timeline sketched implies meaningful capital intensity does not arrive until well after 2026, so the equity could lose momentum if lithium prices soften before the next regulatory milestone lands. Also, the ASX listing is a visibility event, not a financing event; if investors misread it as a de-risking of growth funding, sentiment could overshoot and then disappoint when no fresh capital or M&A catalyst appears.

Key Decisions for Investors

• Go long LAR on weakness over the next 1-2 weeks; the setup favors a rerating toward cash-flow quality as Q2/Q3 distributions become visible. Risk/reward is attractive if realized-price discounts narrow faster than modeled.
• Buy LAR call spreads out 3-6 months to capture upside from lithium spot strength and potential RIGI approval, while limiting downside if permitting slips. Best expression: upside into midyear milestones, not a long-dated widowmaker.
• Pair trade: long LAR / short a higher-cost lithium producer over 1-2 quarters. The relative value thesis is that low-cost brine operators with self-funded growth should outperform names still dependent on external capital.
• Take profits on any fast move following ASX-listing headlines. That event is likely to be a visibility catalyst, not a fundamental step-change, so the trade can become crowded before the economics change.
• If lithium prices roll over for 4-6 weeks, reduce exposure rather than averaging down. LAR’s operating leverage cuts both ways, and the stock’s multiple expansion depends on the market believing current pricing is not purely cyclical.